Litchfield, Kevin, Stanislaw, Stacey, Spain, Lavinia, Gallegos, Lisa L, Rowan, Andrew, Schnidrig, Desiree, Rosenbaum, Heidi, Harle, Alexandre, Au, Lewis, Hill, Samantha M et al (show 22 more authors)
(2020)
Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue.
CELL REPORTS, 31 (5).
107550-.
ISSN 2211-1247, 2211-1247
Text
PIIS2211124720304605.pdf - Published version Download (3MB) | Preview |
Abstract
Although thousands of solid tumors have been sequenced to date, a fundamental under-sampling bias is inherent in current methodologies. This is caused by a tissue sample input of fixed dimensions (e.g., 6 mm biopsy), which becomes grossly under-powered as tumor volume scales. Here, we demonstrate representative sequencing (Rep-Seq) as a new method to achieve unbiased tumor tissue sampling. Rep-Seq uses fixed residual tumor material, which is homogenized and subjected to next-generation sequencing. Analysis of intratumor tumor mutation burden (TMB) variability shows a high level of misclassification using current single-biopsy methods, with 20% of lung and 52% of bladder tumors having at least one biopsy with high TMB but low clonal TMB overall. Misclassification rates by contrast are reduced to 2% (lung) and 4% (bladder) when a more representative sampling methodology is used. Rep-Seq offers an improved sampling protocol for tumor profiling, with significant potential for improved clinical utility and more accurate deconvolution of clonal structure.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | PEACE Consortium, Humans, Lung Neoplasms, Biopsy, Tumor Burden, Mutation, Urinary Bladder Neoplasms, High-Throughput Nucleotide Sequencing, Biomarkers, Tumor |
Depositing User: | Symplectic Admin |
Date Deposited: | 21 May 2020 09:00 |
Last Modified: | 07 Dec 2024 19:49 |
DOI: | 10.1016/j.celrep.2020.107550 |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3088187 |